197 related articles for article (PubMed ID: 37190108)
1. Parsimonious Effect of Pentoxifylline on Angiogenesis: A Novel Pentoxifylline-Biased Adenosine G Protein-Coupled Receptor Signaling Platform.
Khoury W; Trus R; Chen X; Baghaie L; Clark M; Szewczuk MR; El-Diasty M
Cells; 2023 Apr; 12(8):. PubMed ID: 37190108
[TBL] [Abstract][Full Text] [Related]
2. Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline-A study using zebrafish model.
Nathan JR; Lakshmanan G; Michael FM; Seppan P; Ragunathan M
Biomed Pharmacother; 2016 Dec; 84():1406-1418. PubMed ID: 27802896
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways.
Kreth S; Ledderose C; Luchting B; Weis F; Thiel M
Shock; 2010 Jul; 34(1):10-6. PubMed ID: 19997047
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Osteopenia in Ovariectomized Rats by Pentoxifylline: Evidence of Osteogenic and Osteo-Angiogenic Roles of the Drug.
Pal S; Porwal K; Singh H; Malik MY; Rashid M; Kulkarni C; Khan Y; Jagavelu K; Wahajuddin M; Chattopadhyay N
Calcif Tissue Int; 2019 Sep; 105(3):294-307. PubMed ID: 31175387
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline.
Gude RP; Binda MM; Boquete AL; Bonfil RD
J Cancer Res Clin Oncol; 2001 Oct; 127(10):625-30. PubMed ID: 11599799
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline inhibits angiogenesis via decreasing Dll4 and Notch1 expression in mouse proepicardial explant cultures.
Niderla-Bielińska J; Bartkowiak K; Ciszek B; Czajkowski E; Jankowska-Steifer E; Krejner A; Ratajska A
Eur J Pharmacol; 2018 May; 827():80-87. PubMed ID: 29535000
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
Kamran MZ; Gude RP
Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis.
Windmeier C; Gressner AM
Gen Pharmacol; 1997 Aug; 29(2):181-96. PubMed ID: 9251897
[TBL] [Abstract][Full Text] [Related]
9. Effects of pentoxifylline on peritoneal fibroblasts and silica-induced peritoneal fibrosis.
Fang CC; Lai MN; Chien CT; Hung KY; Tsai CC; Tsai TJ; Hsieh BS
Perit Dial Int; 2003; 23(3):228-36. PubMed ID: 12938822
[TBL] [Abstract][Full Text] [Related]
10. [Effect of pentoxifylline on the vascular toxicity secondary to cyclosporine in rats].
Latulippe JF; Buluran J; Cartier R
Ann Chir; 1995; 49(8):712-8. PubMed ID: 8561426
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline inhibits T-cell adherence to keratinocytes.
Bruynzeel I; van der Raaij LM; Stoof TJ; Willemze R
J Invest Dermatol; 1995 Jun; 104(6):1004-7. PubMed ID: 7539468
[TBL] [Abstract][Full Text] [Related]
12. The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice.
Bałan BJ; Demkow U; Skopiński P; Bychawska M; Skopińska-Różewska E; Lewicki S; Zdanowski R
Cent Eur J Immunol; 2017; 42(2):131-139. PubMed ID: 28860931
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
14. Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.
Goel PN; Gude RP
Mol Cell Biochem; 2011 Dec; 358(1-2):141-51. PubMed ID: 21725843
[TBL] [Abstract][Full Text] [Related]
15. A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity.
Nasiri-Toosi Z; Dashti-Khavidaki S; Khalili H; Lessan-Pezeshki M
Eur J Clin Pharmacol; 2013 May; 69(5):1057-73. PubMed ID: 23179178
[TBL] [Abstract][Full Text] [Related]
16. The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.
Fredholm BB; Lindström K
Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):187-92. PubMed ID: 3012941
[TBL] [Abstract][Full Text] [Related]
17. Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
J Urol; 1994 Jun; 151(6):1697-702. PubMed ID: 8189599
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase.
Hammerman C; Goldschmidt D; Caplan MS; Kaplan M; Schimmel MS; Eidelman AI; Branski D; Hochman A
J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):69-74. PubMed ID: 10400107
[TBL] [Abstract][Full Text] [Related]
19. Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells.
Goel PN; Gude RP
Eur J Pharmacol; 2013 Aug; 714(1-3):432-41. PubMed ID: 23872375
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors.
Peterson TC
Biochem Pharmacol; 1996 Aug; 52(4):597-602. PubMed ID: 8759032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
